Pneumococcal vaccine strategy. Feasibility of a vaccination program directed at hospitalized and ambulatory patients Academic Article Article uri icon


MeSH Major

  • Diabetes Mellitus, Type 2
  • Hemoglobin A, Glycosylated
  • Hypoglycemic Agents


  • A prospective analysis of patients hospitalized with pneumococcal infection at two Rochester (NY) hospitals was performed during an 18-month period to assess the feasibility of a pneumococcal vaccination program directed at inpatients. Of the 113 patients hospitalized with pneumococcal infection, only nine patients (8%) had previously received pneumococcal vaccine and 76 patients (67%) had been hospitalized at least once in the previous three years. Of the 104 patients who had a source of regular medical care, 100% had made at least one outpatient visit in the previous three years. The association between the acquisition of a serious pneumococcal infection and hospitalization within the previous three years suggests that a vaccination strategy directed at hospitalized high-risk patients would be potentially effective. Also, vaccination of high-risk ambulatory patients remains a viable strategy to prevent serious pneumococcal infection.

publication date

  • January 1984



  • Academic Article


Digital Object Identifier (DOI)

  • 10.1001/archinte.144.9.1755

PubMed ID

  • 6476992

Additional Document Info

start page

  • 1755

end page

  • 7


  • 144


  • 9